
Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High
InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were demonstrated on both of the key secondary endpoints of six-minute … Continue reading Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High